Tesla says it values China suppliers, does not exclude any by origin

Tesla China VP Grace Tao said on Weibo that Tesla does not exclude suppliers based on country of origin, responding to a Wall Street Journal report about U.S. production rules. She highlighted that Shanghai’s plant sources over 95% of components locally for the China-made Model 3 and refreshed Model Y, relies on more than 400 domestic suppliers (over 60 of which also supply globally), and sells the Model 3 from 235,500 yuan (~$33,250) versus $36,990 in the U.S., underscoring localized supply-chain resilience amid broader industry moves such as GM asking suppliers to scrub China parts.

Analysis

Market structure: Tesla (TSLA) is the clear near-term winner — its Shanghai supply base (>400 domestic suppliers, >60 global suppliers) supports COGS advantages implied by a China Model 3 at ¥235,500 (~$33.3k) vs US $36.99k (~10% price edge). Legacy US OEMs (e.g., GM) and US-headquartered suppliers that are forced to de-China their chains face margin compression from reshoring costs of 5–15% on affected parts over 12–24 months. Pricing power shifts toward OEMs with high local-content flexibility; consequence is potential market-share gains for Tesla in China and lower-tier OEMs that replicate the China-sourcing model.

Risk assessment: Tail risks include US policy action banning China-sourced components for US plants (low probability, high impact) which could raise Tesla US COGS by an estimated 5–12% and disrupt suppliers globally; reciprocal Chinese measures or inspections are a mid-probability operational risk. Time horizons: expect headline-driven volatility in days, contract renegotiations over weeks–months, and structural reshoring/decoupling outcomes over 1–3 years. Hidden dependencies include concentration among the ~60 globally-integrated Chinese suppliers — single-supplier shocks or blacklistings could propagate to global production.

Trade implications: Tactical trades — establish a 2–3% long TSLA position funded by a 1–2% short GM (GM) position to capture relative margin divergence over 3–12 months; complement with a defined-risk TSLA 3–6 month call spread (buy near-ATM, sell +25–35% strike) sized 1% notional to limit downside. Buy 3–9 month puts on GM sized 0.5–1% to hedge legacy OEM downside if supplier delisting accelerates; rotate portfolio +3% into Chinese auto suppliers/parts makers listed or ETFs with >=30% China exposure while trimming US OEM exposure similarly.

Contrarian angles: Consensus assumes wholesale decoupling; reality is nuanced — Tesla explicitly says country-of-origin not exclusionary which implies policy flexibility and legal workaround potential. If TSLA shares dip >15% on geopolitics, accumulation is attractive because long-run manufacturing economics (localization, scale) favor Tesla; historical parallel: 2018–19 trade shocks produced short-lived volatility but persistent winners were firms with localized cost bases. Unintended consequence: aggressive US supplier scrubbing may accelerate China’s tech independence, ultimately entrenching Chinese suppliers and reducing US OEM bargaining power over 1–3 years.

Key Decisions for Investors

• Establish a 2–3% long position in TSLA (shares) over the next 2–6 weeks to capture China cost advantages; size to risk budget and consider stop-loss at a 20% drawdown.
• Initiate a 1–2% short position in GM (shares) paired with the TSLA long (long TSLA, short GM) to play relative margin and market-share divergence over a 3–12 month horizon.
• Buy a defined-risk TSLA 3–6 month call spread (near-ATM buy / sell +25–35% strike) sized to 1% notional to exploit upside while capping premium outlay; enter within 30 days or on any >8% pullback in TSLA.
• Purchase 3–9 month GM puts (size 0.5–1% notional) if GM fails to publicly commit to China-agnostic supplier policies within 60 days, hedging potential margin squeeze from reshoring costs.
• Overweight (add ~3% portfolio tilt) into China-focused auto supply-chain ETFs or large-cap Chinese EV suppliers that report >30% revenue from Tesla within 6–12 months; trim legacy US OEM exposure by ~2–4% concurrently.